Phillip Foreman

Phillip Foreman has been a Director of TheraBiogen, Inc. since August 31, 2008.
Dr. Forman was appointed as Medical Director of the New York Hyperbaric in 2001.
From July 2005 to January 18, 2007, he served as Chief Executive Officer of American Hyperbaric, Inc. Previously, Dr. Forman was a Principal at Merck & Co., Inc., Pharmacia, OrthoBiotech, Novartis/Organogenesis, Johnson & Johnson, Monsanto, Ortho-McNiel, Alpha Therapeutics, and Ortec International.
He was a Principal at Staten Island University Hospital and Associate and a Director of Residency Program for Staten Island University Hospital.
Dr. Forman has extensive experience in wound care.
He received a degree from the American Board of Podiatric Surgery and a PhD in Podiatric Medicine from the Pennsylvania College of Podiatric Medicine.